Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovic Lacroix

Showing results (61-70 of 180) with videos related to

Pageof 18
Sort By:
International Journal of Molecular Sciences|July 29, 2023
Combined Tumor-Based <i>BRCA1/2</i> and <i>TP53</i> Mutation Testing in Ovarian CancerEdith Borcoman, Elizabeth Santana Dos Santos, Catherine Genestie, et al.
Journal of the National Cancer Institute|November 15, 2007
Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor geneQingguo Tao, Junya Fujimoto, Taoyan Men, et al.
Thyroid : Official Journal of the American Thyroid Association|November 22, 2013
Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by reverse phase protein arraySophie Broutin, Frédéric Commo, Leanne De Koning, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2006
Sodium/iodide symporter (NIS) gene expression is the limiting step for the onset of thyroid function in the human fetusGabor Szinnai, Ludovic Lacroix, Aurore Carré, et al.
Cancers|February 25, 2022
Anaplastic Thyroid Carcinoma: An UpdateArnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, et al.
Thyroid : Official Journal of the American Thyroid Association|July 5, 2013
Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by reverse phase protein arraySophie Broutin, Frédéric Commo, Leanne De Koning, et al.
Endocrine-Related Cancer|December 15, 2010
Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumorsCatherine Ory, Nicolas Ugolin, Céline Levalois, et al.
Molecular Oncology|August 25, 2016
Concordance between HER-2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patientsClaudia Rodriguez, Voichita Suciu, Audrey Poterie, et al.
Breast Cancer Research and Treatment|October 18, 2019
Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studiesDimitri Carene, Alicia Tran-Dien, Jérôme Lemonnier, et al.
Endocrine-Related Cancer|September 26, 2009
Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissuesUrbain Weyemi, Bernard Caillou, Monique Talbot, et al.
Pageof 18

Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
International Journal of Molecular Sciences|July 29, 2023
Combined Tumor-Based <i>BRCA1/2</i> and <i>TP53</i> Mutation Testing in Ovarian CancerEdith Borcoman, Elizabeth Santana Dos Santos, Catherine Genestie, et al.
Journal of the National Cancer Institute|November 15, 2007
Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor geneQingguo Tao, Junya Fujimoto, Taoyan Men, et al.
Thyroid : Official Journal of the American Thyroid Association|November 22, 2013
Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by reverse phase protein arraySophie Broutin, Frédéric Commo, Leanne De Koning, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2006
Sodium/iodide symporter (NIS) gene expression is the limiting step for the onset of thyroid function in the human fetusGabor Szinnai, Ludovic Lacroix, Aurore Carré, et al.
Cancers|February 25, 2022
Anaplastic Thyroid Carcinoma: An UpdateArnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, et al.
Thyroid : Official Journal of the American Thyroid Association|July 5, 2013
Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by reverse phase protein arraySophie Broutin, Frédéric Commo, Leanne De Koning, et al.
Endocrine-Related Cancer|December 15, 2010
Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumorsCatherine Ory, Nicolas Ugolin, Céline Levalois, et al.
Molecular Oncology|August 25, 2016
Concordance between HER-2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patientsClaudia Rodriguez, Voichita Suciu, Audrey Poterie, et al.
Breast Cancer Research and Treatment|October 18, 2019
Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studiesDimitri Carene, Alicia Tran-Dien, Jérôme Lemonnier, et al.
Endocrine-Related Cancer|September 26, 2009
Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissuesUrbain Weyemi, Bernard Caillou, Monique Talbot, et al.
Pageof 18